tiprankstipranks
Zepp Health Corporation (ZEPP)
NYSE:ZEPP
Want to see ZEPP full AI Analyst Report?

Zepp Health (ZEPP) Price & Analysis

465 Followers

ZEPP Stock Chart & Stats

$16.76
$0.05(1.72%)
At close: 4:00 PM EST
$16.76
$0.05(1.72%)

Bulls Say, Bears Say

Bulls Say
Revenue Growth TractionSustained top‑line momentum across tiers and a multi‑quarter revenue guide indicate the company is regaining scale. Durable revenue growth driven by new product cycles and broader geographic share supports operating leverage and is a prerequisite for converting recent margin improvements into lasting profitability.
Premiumization / ASP ExpansionA >20% ASP increase and a shifted product mix toward higher‑priced models create structural pricing power. Higher ASPs raise revenue per unit, improve gross margins absent cost inflation, and reduce dependence on unit volume—strengthening sustainable margin profile as premium positioning deepens.
Ecosystem Partnership & LiquidityThe HYROX deal broadens product categories, embeds Zepp in a fitness ecosystem and supports long‑term monetization via specialized modes and content. Combined with a cash balance (~$103.2M) and prior debt retirements, this strengthens runway to invest in ecosystem expansion and capture recurring software/service opportunities.
Bears Say
Persistent LossesAlthough losses narrowed, adjusted net losses remain sizeable and free cash flow was negative in 2024–2025. Continued operating deficits undermine internal funding, force reliance on balance‑sheet support or capital markets, and extend the time needed to reach self‑sustaining profitability.
Rising Leverage & Debt TimingLeverage rising to roughly parity with equity and reclassification of borrowings to short‑term raises refinancing and liquidity risk. Higher leverage constrains financial flexibility, increases interest/covenant sensitivity, and limits ability to fund growth initiatives without raising costly external capital.
Component Cost & FX PressureAn industry shift to DDR5 and other higher‑cost components materially pressures gross margins. Coupled with unfavorable FX impacts on operating expenses, these structural input-cost and currency headwinds can erode the pricing gains from premiumization and slow margin recovery unless mitigated by sourcing or product mix shifts.

Zepp Health News

ZEPP FAQ

What was Zepp Health Corporation’s price range in the past 12 months?
Zepp Health Corporation lowest stock price was $3.85 and its highest was $61.85 in the past 12 months.
    What is Zepp Health Corporation’s market cap?
    Zepp Health Corporation’s market cap is $79.86M.
      When is Zepp Health Corporation’s upcoming earnings report date?
      Zepp Health Corporation’s upcoming earnings report date is Aug 26, 2026 which is in 34 days.
        How were Zepp Health Corporation’s earnings last quarter?
        Zepp Health Corporation released its earnings results on Jun 09, 2026. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
          Is Zepp Health Corporation overvalued?
          According to Wall Street analysts Zepp Health Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Zepp Health Corporation pay dividends?
            Zepp Health Corporation pays a Notavailable dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Zepp Health Corporation dividends here
              What is Zepp Health Corporation’s EPS estimate?
              Zepp Health Corporation’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Zepp Health Corporation have?
              Zepp Health Corporation has 8,460,126 shares outstanding.
                What happened to Zepp Health Corporation’s price movement after its last earnings report?
                Zepp Health Corporation reported an EPS of -$0.07 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -28.641%.
                  Which hedge fund is a major shareholder of Zepp Health Corporation?
                  Currently, no hedge funds are holding shares in ZEPP
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Zepp Health Corporation

                    Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.

                    Zepp Health (ZEPP) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    GoPro
                    Koss
                    Universal Electronics
                    Vuzix
                    Wearable Devices Ltd.

                    Ownership Overview

                    12.61%3.60%3.10%80.34%
                    12.61% Insiders
                    3.10% Other Institutional Investors
                    80.34% Public Companies and
                    Individual Investors
                    Popular Stocks